Home › Melanoma
Pag-aaral pangklinika para sa Melanoma na nagre-recruit sa U.S.
196 pag-aaral para sa Melanoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX61 pag-aaral
- New York City, NY41 pag-aaral
- Nashville, TN34 pag-aaral
- Los Angeles, CA34 pag-aaral
- Pittsburgh, PA31 pag-aaral
- Boston, MA25 pag-aaral
- St. Louis, MO23 pag-aaral
- Durham, NC22 pag-aaral
- Philadelphia, PA22 pag-aaral
- Tampa, FL21 pag-aaral
- Columbus, OH21 pag-aaral
- Dallas, TX21 pag-aaral
- San Francisco, CA21 pag-aaral
- Denver, CO19 pag-aaral
- Atlanta, GA19 pag-aaral
- Arlington, VA19 pag-aaral
- Salt Lake City, UT19 pag-aaral
- Aurora, CO18 pag-aaral
- Washington, DC18 pag-aaral
- Queens, NY17 pag-aaral
- San Diego, CA17 pag-aaral
- Orlando, FL17 pag-aaral
- Edison, NJ17 pag-aaral
- Grand Rapids, MI17 pag-aaral
- Jacksonville, FL16 pag-aaral
- Seattle, WA16 pag-aaral
- San Antonio, TX16 pag-aaral
- Rochester, MN16 pag-aaral
- Cincinnati, OH16 pag-aaral
- Madison, WI15 pag-aaral
- Portland, OR15 pag-aaral
- Chicago, IL15 pag-aaral
- Cleveland, OH14 pag-aaral
- Orange, CA14 pag-aaral
- New Haven, CT12 pag-aaral
- Minneapolis, MN12 pag-aaral
- Ann Arbor, MI12 pag-aaral
- Birmingham, AL12 pag-aaral
- Mountain View, CA12 pag-aaral
- Omaha, NE12 pag-aaral
Ayos sa estado
- Alabama13 pag-aaral
- Alaska5 pag-aaral
- Arizona26 pag-aaral
- Arkansas11 pag-aaral
- California69 pag-aaral
- Colorado33 pag-aaral
- Connecticut15 pag-aaral
- Delaware6 pag-aaral
- District of Columbia8 pag-aaral
- Florida56 pag-aaral
- Georgia21 pag-aaral
- Hawaii3 pag-aaral
- Idaho8 pag-aaral
- Illinois22 pag-aaral
- Indiana13 pag-aaral
- Iowa13 pag-aaral
- Kansas15 pag-aaral
- Kentucky20 pag-aaral
- Louisiana8 pag-aaral
- Maine4 pag-aaral
- Maryland24 pag-aaral
- Massachusetts28 pag-aaral
- Michigan30 pag-aaral
- Minnesota29 pag-aaral
- Mississippi3 pag-aaral
- Missouri25 pag-aaral
- Montana8 pag-aaral
- Nebraska16 pag-aaral
- Nevada6 pag-aaral
- New Hampshire6 pag-aaral
- New Jersey25 pag-aaral
- New Mexico11 pag-aaral
- New York52 pag-aaral
- North Carolina32 pag-aaral
- North Dakota9 pag-aaral
- Ohio41 pag-aaral
- Oklahoma15 pag-aaral
- Oregon15 pag-aaral
- Pennsylvania47 pag-aaral
- Rhode Island5 pag-aaral
- South Carolina10 pag-aaral
- South Dakota7 pag-aaral
- Tennessee42 pag-aaral
- Texas79 pag-aaral
- Utah23 pag-aaral
- Vermont5 pag-aaral
- Virginia33 pag-aaral
- Washington25 pag-aaral
- West Virginia7 pag-aaral
- Wisconsin21 pag-aaral
- Wyoming3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Nagre-recruitPhase 1/2
6 Months – 17 Years · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT02332668High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
Nagre-recruit
Edad 19 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05053555Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma
Nagre-recruitPhase 2
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05155033Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04751396BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT05136196Evaluation for NCI Surgery Branch Clinical Research Protocols
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT00001823BostonGene and Exigent Genomic INsight Study
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06272864A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06270706Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07148245Adjuvant/Neoadjuvant Immunotherapy in Melanoma Based on Serial Plasma ctDNA Monitoring
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07930182Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT03941756Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Nagre-recruitPhase 1
Edad 12 hanggang 50 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT03093909A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Nagre-recruitPhase 1
Edad 18 hanggang 120 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT06066138IL-17 Blockade to Decrease irAEs (REPLAY)
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT07237594A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT05077137A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT06246916Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 6, 2026 · NCT04198766Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07519655A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06150664Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05334069Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05830058Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT06418204SI-B036-ST-101 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07857616A Study of Navlimetostat (BMS-986504) Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07492680Safety and Efficacy of OBX-115 in Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT06060613Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.